CYTOKINETICS INC Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cytokinetics Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Cytokinetics Inc Debt-to-equity for the quarter ending September 30, 2024 was -768 %, a 87.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -768 -359 -87.7% Sep 30, 2024
Q2 2024 -450 +198 +30.5% Jun 30, 2024
Q1 2024 -303 +1.35K +81.7% Mar 31, 2024
Q4 2023 -333 -3.82K -110% Dec 31, 2023
Q3 2023 -409 -1.09K -160% Sep 30, 2023
Q2 2023 -648 -1.01K -281% Jun 30, 2023
Q1 2023 -1.65K -2.05K -520% Mar 31, 2023
Q4 2022 3.48K +3.1K +800% Dec 31, 2022
Q3 2022 678 +218 +47.4% Sep 30, 2022
Q2 2022 358 -161 -31.1% Jun 30, 2022
Q1 2022 394 -225 -36.4% Mar 31, 2022
Q4 2021 387 -589 -60.3% Dec 31, 2021
Q3 2021 460 -7.86K -94.5% Sep 30, 2021
Q2 2021 519 +1.24K Jun 30, 2021
Q1 2021 619 +1.86K Mar 31, 2021
Q4 2020 975 +3.78K Dec 31, 2020
Q3 2020 8.32K -9.09K -52.2% Sep 30, 2020
Q2 2020 -725 -1.72K -173% Jun 30, 2020
Q1 2020 -1.24K -1.71K -367% Mar 31, 2020
Q4 2019 -2.8K -3.09K -1090% Dec 31, 2019
Q3 2019 17.4K +17.2K +8094% Sep 30, 2019
Q2 2019 996 +830 +500% Jun 30, 2019
Q1 2019 467 +333 +249% Mar 31, 2019
Q4 2018 283 +150 +113% Dec 31, 2018
Q3 2018 213 +97.1 +84.1% Sep 30, 2018
Q2 2018 166 +58.2 +53.9% Jun 30, 2018
Q1 2018 134 +17.1 +14.7% Mar 31, 2018
Q4 2017 133 +41.1 +44.8% Dec 31, 2017
Q3 2017 115 +25.9 +28.9% Sep 30, 2017
Q2 2017 108 +27.8 +34.7% Jun 30, 2017
Q1 2017 117 +51.5 +79.2% Mar 31, 2017
Q4 2016 91.7 +38.3 +71.7% Dec 31, 2016
Q3 2016 89.6 +41.9 +88% Sep 30, 2016
Q2 2016 80.1 +40 +99.5% Jun 30, 2016
Q1 2016 65 +31.6 +94.3% Mar 31, 2016
Q4 2015 53.4 +25.3 +89.8% Dec 31, 2015
Q3 2015 47.7 +20.1 +72.7% Sep 30, 2015
Q2 2015 40.2 -4.45 -9.98% Jun 30, 2015
Q1 2015 33.5 -27.1 -44.7% Mar 31, 2015
Q4 2014 28.1 -33.4 -54.2% Dec 31, 2014
Q3 2014 27.6 -19.9 -41.9% Sep 30, 2014
Q2 2014 44.6 +21.2 +90.8% Jun 30, 2014
Q1 2014 60.5 +53 +702% Mar 31, 2014
Q4 2013 61.5 +54.1 +735% Dec 31, 2013
Q3 2013 47.5 +40.6 +589% Sep 30, 2013
Q2 2013 23.4 +15.7 +203% Jun 30, 2013
Q1 2013 7.55 -1.66 -18% Mar 31, 2013
Q4 2012 7.37 Dec 31, 2012
Q3 2012 6.89 Sep 30, 2012
Q2 2012 7.7 Jun 30, 2012
Q1 2012 9.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.